Bevacizumab Injection for Recurrent Pterygium
Triple Subconjunctival Bevacizumab Injection for Early Recurrent Pterygium. One Year Follow-up
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana
This observational or N/A phase trial investigates Recurrent Pterygium and is currently completed. Instituto de Oftalmología Fundación Conde de Valenciana leads this study, which shows 8 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
Phase: PHASE1 → NA
-
Jan 2017 — Mar 2018 [monthly]
Completed PHASE1
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto de Oftalmología Fundación Conde de Valenciana
- National Council of Science and Technology, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .